Skip to content
LexBuild

New Animal Drugs; Change of Sponsor's Name and Address

---
identifier: "/us/fr/02-7147"
source: "fr"
legal_status: "authoritative_unofficial"
title: "New Animal Drugs; Change of Sponsor's Name and Address"
title_number: 0
title_name: "Federal Register"
section_number: "02-7147"
section_name: "New Animal Drugs; Change of Sponsor's Name and Address"
positive_law: false
currency: "2002-03-26"
last_updated: "2002-03-26"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "02-7147"
document_type: "rule"
publication_date: "2002-03-26"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
cfr_references:
  - "21 CFR Part 510"
fr_citation: "67 FR 13717"
fr_volume: 67
effective_date: "2002-03-26"
fr_action: "Final rule."
---

#  Names, addresses, and drug labeler codes of sponsors of approved applications.

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Final rule.

**SUMMARY:**

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor's name and address for G.D. Searle & Co.

**DATES:**

This rule is effective March 26, 2002.

**FOR FURTHER INFORMATION CONTACT:**

Lonnie W. Luther, Center for Veterinary Medicine (HFV-102), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-827-0209, e-mail: [email protected].

**SUPPLEMENTARY INFORMATION:**

G.D. Searle & Co., P.O. Box 5110, Chicago, IL 60680, has informed FDA of a change of name and address to G.D. Searle LLC, Pharmacia Corp., 4901 Searle Pkwy., Skokie, IL 60077. Accordingly, the agency is amending the regulations in 21 CFR 510.600(c)(1) and (c)(2) to reflect the change.

This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.

**List of Subjects in 21 CFR Part 510**

Administrative practice and procedure, Animal drugs, Labeling, Reporting and recordkeeping requirements.

**21 CFR Part 510**

Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 510 is amended as follows:

**PART 510—NEW ANIMAL DRUGS**

1. The authority citation for 21 CFR part 510 continues to read as follows:

**Authority:**

21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.

2. Section 510.600 is amended in the table in paragraph (c)(1) by revising the entry for “G.D. Searle & Co.” and in the table in paragraph (c)(2) by revising the entry for “000014” to read as follows:

§ 510.600

(c) * * *

(1) * * *

| Firm name and address | Drug labeler code |
| --- | --- |
|  | *         *         *         *         *         *         * |
| G.D. Searle LLC, Pharmacia Corp., 4901 Searle Pkwy., Skokie, IL 60077 | 000014 |
|  | *         *         *         *         *         *         * |

(2) * * *

| Drug labeler code | Firm name and address |
| --- | --- |
|  |  |
| *         *         *         *         *         *         * |  |
| 000014 | G.D. Searle LLC, Pharmacia Corp., 4901 Searle Pkwy., Skokie, IL 60077 |
|  |  |
| *         *         *         *         *         *         * |  |

Dated: February 22, 2002.

Claire M. Lathers,

Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine.